A new think tank study dismisses a proposal from Iowa Republican Charles Grassley to require disclosure of medical device pricing. (Picture from the PiperReport.) The hit piece was commissioned by AdvaMed, the device industry trade group, and claimed that there is little market competition, that search costs are high, and so the plan just wouldn't work. Maybe not. Not at first. But the key to the plan is in the bill's title. It's the Transparency in Medical Device Pricing Act. I emphasized this key point so the study's authors can read it without their spectacles. Transparency is abhorrent to the entire medical industry, and folks across the political spectrum are growing weary of it. While driving back from HIMSS yesterday, for...